FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmaceutical industry, namely to a composition containing acetocyclopropyl-taxotere and Trastuzumab used for treating breast cancer, for treating taxoid resistant cancer types.
EFFECT: preparation of the pharmaceutical composition for treating breast cancer.
2 cl, 1 tbl
| Title |
Year |
Author |
Number |
| ANTI-CANCER COMBINATIONS CONTAINING VEGF INHIBITOR AND IRINOTECAN |
2008 |
- Bisseri Mari-Kristin
- Shiron-Blondel' Mariell'
- Lezhen Paskal'
- Vrin'O Patris'Ja
|
RU2471483C2 |
| TREATMENT OF CANCER BY COMBINATION OF PLINABULIN AND TAXANE |
2013 |
|
RU2662298C2 |
| MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE-3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER |
2013 |
- Belvin Marsiya
- Fridman Lori
- Sampat Dipak
- Vallin Dzheffri
|
RU2665949C2 |
| DRUG EFFECTIVE FOR LYMPHOGENIC METHOD FOR THE INJECTION OF DRUG |
2017 |
- Kodama, Tetsuya
- Mori, Siro
- Nokhara, Go
|
RU2759640C2 |
| ANTITUMOR COMPOSITION CONTAINING TAXANE DERIVATIVES |
1993 |
|
RU2131250C1 |
| COMBINATIONS OF ANTI-HER2-ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC REMEDIES, AND APPLICATION METHODS |
2018 |
- Berry, Leanne
- Phillips, Gail, Lewis
- Sliwkowski, Mark, X.
|
RU2781195C2 |
| COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS AND METHODS OF USE |
2013 |
- Berri Linn
- Fillips Gejl Lyuis
- Slivkovski Mark Ks.
|
RU2671489C2 |
| COMBINATIONS OF ANTIBODY DRUG CONJUGATES AND CHEMOTHERAPEUTIC COMPOUNDS AND METHODS FOR USING |
2009 |
- Berri Linn
- Fillips Gejl L'Juis
- Slivkovski Mark Ks.
|
RU2510272C2 |
| COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER, INCLUDING A VESSEL-DESTROYING AGENT AND A TAXANE COMPOUND |
2019 |
|
RU2761826C1 |
| COMBINATIONS OF INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE AND CHEMIOTHERAPEUTIC AGENTS AND METHODS OF APPLICATION |
2008 |
- Belvin Marsija
- Fridman Lori
- Kheflikh Klaus
- Sampat Dipak
- Vidzhapurkar Ulka
- Vallin Dzheffri
- Dzhonson Lejza
- Singkh Mallika
- Patel' Sonal'
|
RU2523890C2 |
